您现在位置： -医药产业 >> 研究报告 >> English reports >> English reports >> 浏览医药行业研究报告

Carbapenem antimicrobial drugs Report  (2007 Edition)

讯：

    There are important changes in 2006's carbapenems markt in China. Four enterprises go into the market, including the forth carbapenem drug Ertapenem(brand name : INVANZTM) and three Imipenem products including Inida RANBAXY's "BACQURE", Korea Choongwae Pharma Corporation's "Prepenem" and Shenzhen Haibin Pharmaceutical Co., Ltd's "SuNeng". The competitive enterprises increase to 9 from 5 and the new brands represent rapid increase, especially import brands.

    In order to reflect the practical sales size, we combine the practical import amount of certain brands and the sales data from 250 sample hospital to estimate out the market size of Chinese carbapenems markt. The report also presents the competitive status, the development trend of carbapenems, the production and export status of bulk carbapenems, the need amount for bulk carbapenems. This report can provide valuable information and comments for the enterprises which want to know Chinese carbapenems markt or the export of bulk carbapenems.

    Table of Contents Abstract
    Overview of products
    1 General situation of international market of carbapenem Antibiotics
    2 Carbapenem drugs market in China
    2.1 National market scale and growth trend from 2000 to 2006
    2.2 Shares and variation trend of national carbapenem drugs from 2000 to 2006
    2.3 Sale volume and growth trend of Imipenem/Cilastatin from 2000 to2006
    2.4 Sale volume and growth trend of Meropenem from 2001 to 2006
    2.5 Sale volume and growth trend of Panipenem/Betamipron from 2001to 2005
    2.6 Sales Status of Import and Domestic Carbapenem Drugs
    2.7 Evaluation on demand volume of carbapenem Bulk Drugs
    3. Shares of brands
    3.1 Market share variation and advantage appraisal of the 9 brands from 2000 to 2006
    3.1.1 Market share variation of the 6 brands
    3.1.2 Shares of brands in 2006
    3.1.3 Sales Analysis on Different Brand Names of Meropenem from 2000 to 2006
    3.2 Market Shares of Different Brand Names in Sample Cities in 2006
    “Tienam”(Imipenem/Cilastatin)
    “BeiNeng”(Meropenem)
    “Mepem” (Meropenem)
    “Invanztm” (Ertapenem)
    “Carbenin”(Panipenem/Betamipron)
    “Haizheng MeiTe” (Meropenem)
    “BACQURE” (Imipenem/Cilastatin)
     “SuNeng” (Imipenem/Cilastatin)
    “Prepenem” (Imipenem/Cilastatin)
    3.3 Market Shares of Different Brand Names in Major Cities in 2006
    Beijing
    Shanghai
    Guangzhou
    4. Research and Development of new products
    4.1 Domestic and imported products on Chinese market
    4.2 Imitation and Application Status of Carbapenem Antimicrobial Drugs in China
    4.2.1 Types of products
    4.2.2 Application Enterprises
    4.3 Background of other carbapenem drugs about to enter into Chinese market
    Biapenem
    Doripenem
    4.4 Penems products: comparison between Faropenem and carbapenems
    4.5 Clinical evaluation of anti-severe infection drugs
    4.5.1 Main characters of carbapenem antibiotics
    4.5.2 Clinical evaluation of carbapenems
    4.6 Products in process of development in the world currently
    Appendix 1 List of Enterprises Submited Applications for Carbapenems to SFDA
    Appendix 2 Retail Prices of Different Carbapenems with Different Strengths